Vaginal bromocriptine administration in patients with hyperprolactinemia.
Carranza-Lira
S
S
Gynecologic Endocrinology Service, Hospital de Gineco-Obstetricia Luis Castelazo Ayala, Instituto Mexicano del Seguro Social, Mexico City, Mexico. scarranzal@mexis.com
González-Sánchez
J L
JL
Martínez-Chequer
J C
JC
D000282:Administration, Intravaginal; D001971:Bromocriptine / Q000008:administration & dosage*; D018491:Dopamine Agonists / Q000008:administration & dosage*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D006966:Hyperprolactinemia / Q000188:drug therapy*; D007986:Luteinizing Hormone / Q000097:blood; D011388:Prolactin / Q000097:blood; D016896:Treatment Outcome
D018491:Dopamine Agonists; D001971:Bromocriptine; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone